KomiPharm, Foreigners Net Buy 22,756 Shares... Stock Price Up 1.04%
Komipharm is trading at 14,600 KRW as of 1:30 PM on the 16th, up 1.04% from the previous day. This is a decline of 11.52% compared to August 25. Komipharm is known as a manufacturer of veterinary vaccines and disinfectants.
Today, foreigners are tentatively recorded as net buyers of 22,756 shares. Over the past five days, individual investors have net bought 49,359 shares, while foreigners and institutions have net sold 2,893 shares and 62,152 shares, respectively.
On September 8, Komipharm was an issue in the market due to the 'AIFA COVID-19 clinical trial withdrawal news causing weakness.'
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- Second Round of Post-Adjustment Talks at Samsung Electronics Ultimately Fails... Central Labor Relations Commission: "Labor Accepted, Management Reserved Decision"
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- Bull Market End Signal? Securities Firm Warns: "Sell SK hynix 'At This Moment'"
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
